Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Spinal cord stimulation plus rehabilitation for severe chronic neuropathic leg pain

Official title: An Integrated Intervention of Spinal Cord Stimulation and Multidisciplinary Rehabilitation for Chronic Neuropathic Leg Pain: A Single-case Experimental Design Protocol

Run by Oslo University Hospital · NCT07403331 · Data updated 2026-11-12

This project will try combining spinal cord stimulation with a multidisciplinary rehabilitation program to reduce severe nerve pain and improve physical function in adults with chronic neuropathic leg pain.

More Neuropathic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment10 (estimated)
SponsorOslo University Hospital
Academic / other
Locations1 site (Oslo)
StatusRecruiting
StartedMay 4, 2026
Main results expectedApril 1, 2027
Study endsJuly 1, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT07403331 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–60 with chronic (>6 months) peripheral neuropathic pain mainly in one or both legs (post‑spinal pain syndrome or localized nerve damage) who have tried standard treatments, can travel to Oslo, speak Norwegian, and can operate an SCS device.

Probably not a fit

Patients whose pain is not primarily in the legs, who have widespread non‑neuropathic pain, cannot travel to Oslo, lack Norwegian language skills, have cognitive impairment, exceed opioid limits (>50 mg OMEQ daily), or have ongoing compensation/claims issues may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-case experimental design uses repeated measurements within each participant to compare a pre-implant baseline, a randomized short waiting period after implantation, a 12-week active treatment phase combining spinal cord stimulation (SCS) and multidisciplinary rehabilitation, and a five-week follow-up about six months after implantation. Phase A1 is the baseline, A2 is a randomized 2–4 week waiting period, B is the 12‑week SCS+rehabilitation phase (analyzed as early B1 and later B2), and FU is the follow-up period. Primary contrasts are predefined as A1 vs B1 for leg pain intensity and A1 vs B2 for physical function (PROMIS-29), with repeated within-patient measures allowing phase-to-phase comparisons. Eligible participants are adults 18–60 with dominant peripheral neuropathic pain in one or both legs who have tried prior treatments and can attend the Oslo center and use the SCS device.

Why it matters

Potential benefit: If successful, the combined SCS and multidisciplinary program could meaningfully reduce leg neuropathic pain and improve daily physical function and coping.

How similar studies have gone: Previous studies indicate SCS can relieve post‑surgical or injury‑related neuropathic leg pain and multidisciplinary care helps long‑term pain, but combining SCS with a multidisciplinary rehabilitation bundle has not been published.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Peripheral neuropathic pain in one or both legs for \>6 months due to:

  * (1) Post Spinal Pain Syndrome (type 1 or 2).
  * (2) Localized nerve damage.
* The area of the neuropathic pain in the leg(s) must be the dominant pain component.
* Age ranges from 18-60 years.
* Previous standard conservative (or surgical) treatment attempted.
* Opioid use within permissible limits at implantation time (daily opioid dose \<50 mg OMEQ).
* Willingness to actively participate in the treatment bundle.
* Living within reasonable travelling distance from Oslo.
* Proficiency in understanding oral and written Norwegian, essential to benefit from the program that relies on mutual comprehension, nuanced conversation, and emotional expression, which are language-dependent.
* Cognitive capacity to provide informed consent.
* Ability to master the technical aspects of the SCS system (switching programs on the remote control).

Exclusion criteria:

* Currently undergoing the claims process for health benefits (e.g., disability pensions from NAV (Norwegian Labour and Welfare Administration).
* Presenting a psychological or psychiatric disorder that may impact treatment efficacy.
* Chronic generalized pain conditions.
* Other pain conditions in the affected area, such as osteoarthritis.
* Pregnancy.

Where it's running

  • Department of pain management and research, Oslo university hospital
    Oslo, Norway
    Recruiting

Study contacts

  • Principal investigator: Lars-Petter Granan, Ph.D — Department of pain management and research, Oslo university hospital
  • Study coordinator: Christopher Ekholdt, PhD-student
  • Email: chrekh@ous-hf.no
  • Phone: +4723026161

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.